LLY

1,127.49

-0.31%↓

JNJ

233.13

-1.8%↓

ABBV

220.76

-0.61%↓

UNH

409.07

-0.34%↓

MRK

114.02

-1.81%↓

LLY

1,127.49

-0.31%↓

JNJ

233.13

-1.8%↓

ABBV

220.76

-0.61%↓

UNH

409.07

-0.34%↓

MRK

114.02

-1.81%↓

LLY

1,127.49

-0.31%↓

JNJ

233.13

-1.8%↓

ABBV

220.76

-0.61%↓

UNH

409.07

-0.34%↓

MRK

114.02

-1.81%↓

LLY

1,127.49

-0.31%↓

JNJ

233.13

-1.8%↓

ABBV

220.76

-0.61%↓

UNH

409.07

-0.34%↓

MRK

114.02

-1.81%↓

LLY

1,127.49

-0.31%↓

JNJ

233.13

-1.8%↓

ABBV

220.76

-0.61%↓

UNH

409.07

-0.34%↓

MRK

114.02

-1.81%↓

Search

Check Cap Ltd

Closed

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

-9.4K

EBITDA

-1.3M

Market Stats

By TradingEconomics

Market Cap

9.4M

Previous open

0

Previous close

0

Check Cap Ltd Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

About Check Cap Ltd

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
help-icon Live chat